Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
Tagraxofusp-erzs injection is used to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN).
This medicine is to be given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms: